Ricardo Ribeiro Dias

Ricardo Ribeiro Dias

Auto-generated profile, based on publicly available information

Ricardo Ribeiro Dias

Fundação Zerbini, Brasil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FFFabio Fernandes
Fabio Fernandes
MSMarcus V. Simões
Marcus V. Simões
ECEdileide de Barros Correia
Edileide de Barros Correia
FMFabiana Marcondes-Braga
Fabiana Marcondes-Braga
OCOtavio Rizzi Coelho-Filho
Otavio Rizzi Coelho-Filho
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding of its pathogenesis, significant advances in the use of imaging methods, and the more common application of genetic analysis, in addition to a better characterization of the natural history of this myocardial disease, have profoundly reformulated its clinical and prognostic significance. Conversely, these processes were accompanied by the development of new medications addressing molecular mechanisms intrinsically linked to the pathophysiology and pathogenesis [...] 1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding of its pathogenesis, significant advances in the use of imaging methods, and the more common application of genetic analysis, in addition to a better characterization of the natural history of this myocardial disease, have profoundly reformulated its clinical and prognostic significance. Conversely, these processes were accompanied by the development of new medications addressing molecular mechanisms intrinsically linked to the pathophysiology and pathogenesis

1 January 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FFFabio Fernandes
Fabio Fernandes
MSMarcus V. Simões
Marcus V. Simões
ECEdileide de Barros Correia
Edileide de Barros Correia
FMFabiana Marcondes-Braga
Fabiana Marcondes-Braga
OCOtavio Rizzi Coelho-Filho
Otavio Rizzi Coelho-Filho
EMEvandro Tinoco Mesquita
Evandro Tinoco Mesquita
1. Introdução O conhecimento médico científico sobre a cardiomiopatia hipertrófica (CMH) recebeu grande avanço nas últimas décadas. O melhor entendimento da sua patogênese, os avanços expressivos no emprego dos métodos de imagem e a aplicação mais corriqueira da análise genética, além da melhor caracterização da história natural dessa doença miocárdica, trouxeram uma profunda reformulação do seu significado clínico e prognóstico. Por outro lado, esses progressos foram acompanhados do desenvolvimento de novas drogas endereçando mecanismos moleculares intrinsecamente ligados à fisiopatogênese da [...] 1. Introdução O conhecimento médico científico sobre a cardiomiopatia hipertrófica (CMH) recebeu grande avanço nas últimas décadas. O melhor entendimento da sua patogênese, os avanços expressivos no emprego dos métodos de imagem e a aplicação mais corriqueira da análise genética, além da melhor caracterização da história natural dessa doença miocárdica, trouxeram uma profunda reformulação do seu significado clínico e prognóstico. Por outro lado, esses progressos foram acompanhados do desenvolvimento de novas drogas endereçando mecanismos moleculares intrinsecamente ligados à fisiopatogênese da

16 August 2012 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
TGThe MASS-V Study Group
The MASS-V Study Group
WHWhady Hueb
Whady Hueb
BGBernard J Gersh
Bernard J Gersh
PRPaulo Cury Rezende
Paulo Cury Rezende
CGCibele Larrosa Garzillo
Cibele Larrosa Garzillo
RFRoberto Kalil Filho
Roberto Kalil Filho
Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the release, the volume of myocardial tissue loss, and the long-term significance. Delayed-enhancement of cardiac magnetic resonance (CMR) consistently quantifies areas of irreversible myocardial injury. To investigate the quantitative relationship between irreversible injury and cardiac biomarkers, we will evaluate the extent of irreversible injury in patients undergoing PCI and CABG and relate it to postprocedural modifications in cardiac biomarkers and long-term prognosis.

1 December 2010 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
RDRicardo Ribeiro Dias
Ricardo Ribeiro Dias
OMOmar Asdrubal Vilca Mejia
Omar Asdrubal Vilca Mejia
AFAlfredo Inácio Fiorelli
Alfredo Inácio Fiorelli
PPPablo Maria Alberto Pomerantzeff
Pablo Maria Alberto Pomerantzeff
ADAltamiro Ribeiro Dias
Altamiro Ribeiro Dias
NSNoedir Antonio Groppo Stolf
Noedir Antonio Groppo Stolf
Comparative analysis of early and late results of aortic root reconstruction with aortic valve sparing operations and the composite mechanical valve conduit replacement. From November 2002 to September 2009, 164 consecutive patients with mean age 54 ± 15 years, 115 male, underwent the aortic root reconstruction (125 mechanical valve conduit replacements and 39 valve sparing operations). Sixteen percent of patients had Marfan syndrome and 4.3% had bicuspid aortic valve. One hundred and forty-four patients (88%) were followed for a mean period of 41.1 ± 20.8 months. The hospital mortality was 4.9%, 5.6% in operations with valved conduits and 2.6% in the valve sparing procedures (P <0.05). There was no difference neither in survival (95% CI = 86% - 96%, P= 0.1) nor in reoperation-free survival (95% CI = 85% - 90%, P = 0.29). The survival free of complications such as bleeding, thromboembolism and endocarditis were favorable to the valve sparing operations, respectively (95% CI = 70% - 95%, P = 0.001), (95% CI = 82% - 95% P = 0.03) and (95% CI = 81% - 95%, P = 0.03). Multivariate analysis showed that creatinine greater than 1.4 mg/dl, Cabrol operation and renal dialysis were predictors of mortality, respectively, with occurrence chance of 6 (95% CI = 1.8 - 19.5, P = 0.003), 12 (95% CI = 3 - 49.7, P = 0.0004) and 16 (95% CI = 3.6 - 71.3, P = 0.0002). The aortic root reconstruction has a low early and late mortality, high survival free of complications and low need for reoperation. During the late follow-up, valve sparing aortic root reconstructions presented fewer incidences of bleeding, thromboembolic events and endocarditis.

1 January 2021 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
RDRicardo R. Dias
Ricardo R. Dias
JSJosé Augusto Duncan Santiago
José Augusto Duncan Santiago
VJVagner Madrini Junior
Vagner Madrini Junior
CMCharles Mady
Charles Mady
FJFabio B. Jatene
Fabio B. Jatene
The coronavirus disease 2019 (COVID-19) pandemic brought an unprecedented lack of control of what was to come. The intent of this document is to provide a balance of how much was ceased to be done for patients with aortic disease, to assess the mortality of these patients, and to show what happened to those who became COVID-19 positive during their hospitalization. From April 1st to July 31st 2020, the worst period of the pandemic in São Paulo, Brazil, the Institute's aortic surgical patients operated on were evaluated and those were compared with patients operated during the same period in 2019. In 2019, 88 surgeries were performed; most of them were elective (66 [75%]), 10 were urgent, and 12 were emergency surgeries. In 2020, during the COVID-19 pandemic, we operated on only 31 patients, being 74.2% non-elective surgeries (P<0,001). There was a higher mortality for patients operated on during the pandemic surge of COVID-19 (P<0,001), but it was not specifically related to infected patients. The COVID-19 pandemic had an impact on surgical volume and outcome of patients with aortic disease, although it did not directly increase mortality.

1 March 2011 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
DCDaniel Oliveira De Conti
Daniel Oliveira De Conti
RDRicardo Ribeiro Dias
Ricardo Ribeiro Dias
AFAlfredo Inácio Fiorelli
Alfredo Inácio Fiorelli
NSNoedir A. G. Stolf
Noedir A. G. Stolf